CATALOGO DEI PRODOTTI DELLA RICERCA

ZIPETO, Donato
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.731
EU - Europa 10.310
AS - Asia 9.970
SA - Sud America 1.071
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 199
OC - Oceania 39
Totale 35.561
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.233
CN - Cina 4.426
RU - Federazione Russa 3.401
SG - Singapore 3.180
GB - Regno Unito 2.438
IT - Italia 1.350
BR - Brasile 855
VN - Vietnam 799
HK - Hong Kong 629
FR - Francia 589
DE - Germania 550
SE - Svezia 486
IE - Irlanda 476
FI - Finlandia 454
KR - Corea 274
CA - Canada 255
UA - Ucraina 172
IN - India 116
ID - Indonesia 86
BD - Bangladesh 84
NG - Nigeria 76
AR - Argentina 74
NL - Olanda 68
MX - Messico 66
BE - Belgio 64
TR - Turchia 63
JP - Giappone 55
PL - Polonia 44
IQ - Iraq 42
ZA - Sudafrica 41
EC - Ecuador 38
AU - Australia 37
ES - Italia 34
AT - Austria 31
CR - Costa Rica 31
LT - Lituania 30
SV - El Salvador 29
CO - Colombia 26
JM - Giamaica 23
PK - Pakistan 23
UZ - Uzbekistan 23
RO - Romania 22
SA - Arabia Saudita 20
GT - Guatemala 19
JO - Giordania 18
TT - Trinidad e Tobago 17
VE - Venezuela 17
CL - Cile 16
HN - Honduras 16
NI - Nicaragua 16
AE - Emirati Arabi Uniti 14
PH - Filippine 14
PY - Paraguay 14
PE - Perù 13
CW - ???statistics.table.value.countryCode.CW??? 12
IR - Iran 12
MA - Marocco 12
CH - Svizzera 11
KE - Kenya 11
AZ - Azerbaigian 10
EG - Egitto 10
PR - Porto Rico 10
BO - Bolivia 9
DK - Danimarca 9
IL - Israele 9
MY - Malesia 9
TN - Tunisia 9
KZ - Kazakistan 8
NO - Norvegia 8
NP - Nepal 8
SI - Slovenia 8
TG - Togo 8
UY - Uruguay 8
AL - Albania 7
BG - Bulgaria 7
LB - Libano 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
HU - Ungheria 6
KG - Kirghizistan 6
OM - Oman 6
BJ - Benin 5
DZ - Algeria 5
ET - Etiopia 5
EU - Europa 5
LV - Lettonia 5
SN - Senegal 5
BY - Bielorussia 4
GR - Grecia 4
PA - Panama 4
PS - Palestinian Territory 4
PT - Portogallo 4
DO - Repubblica Dominicana 3
GP - Guadalupe 3
HR - Croazia 3
TW - Taiwan 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
EE - Estonia 2
Totale 35.290
Salva come PNG Salva come JPEG
Città #
Ashburn 2.119
Southend 2.051
Singapore 1.702
Jacksonville 1.309
San Jose 1.146
Moscow 1.121
Chandler 1.066
Dallas 962
Verona 662
Hong Kong 617
Ann Arbor 481
Dublin 475
Woodbridge 456
Council Bluffs 451
Beijing 381
Houston 340
The Dalles 271
New York 255
Ho Chi Minh City 247
Los Angeles 205
Wilmington 195
Lawrence 185
Princeton 185
Nanjing 184
Hanoi 144
Jinan 137
Helsinki 127
São Paulo 126
Shenyang 115
Buffalo 104
Tianjin 98
Santa Clara 92
Milan 91
Sindelfingen 90
Munich 89
Changsha 77
Dong Ket 74
Abuja 73
Boardman 73
Hebei 72
Orem 70
Toronto 69
Seattle 68
Nanchang 65
Montreal 64
Ningbo 62
Redondo Beach 62
Haikou 61
Zhengzhou 60
Hangzhou 58
Columbus 57
Brussels 56
Jakarta 56
Atlanta 54
Frankfurt am Main 51
London 51
Redmond 45
Tokyo 44
Da Nang 43
Seoul 43
Taizhou 43
Las Vegas 42
Jiaxing 41
Cambridge 40
Denver 40
Guangzhou 40
Lancaster 39
Rome 38
Chicago 37
Warsaw 36
Taiyuan 34
Brooklyn 32
San Francisco 32
Haiphong 31
Rio de Janeiro 31
Chennai 30
Phoenix 30
Redwood City 30
Johannesburg 28
Lappeenranta 28
San Salvador 26
Norwalk 25
Oxford 25
Stockholm 25
Turku 25
Amsterdam 24
Kent 23
San Diego 23
Bologna 22
Elora 22
Lanzhou 22
The Bronx 22
Vienna 22
Basingstoke 21
Fuzhou 21
Mexico City 21
Shanghai 20
Falls Church 19
Manchester 19
Nuremberg 19
Totale 20.935
Salva come PNG Salva come JPEG
Nome #
CRISPR/Cas9 mediated knock-out of RUNX2 in melanoma cells 1.347
CRISPR/Cas9 genome editing in melanoma cells: new insight of RUNT domain 1.308
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines 381
HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity 307
CRISPR/Cas9 as a tool for studying the interactions between viral and cellular proteins 291
New immunogens for the induction of broad spectrum neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) 288
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 270
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 268
Human T-cell leukemia virus HBZ and APH-2 antisense proteins interaction with host factors and their involvement in NF-Kb activation 262
Gα15 in early onset of pancreatic ductal adenocarcinoma 253
HLA-C presence increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41 252
HLA-C increases HIV-1 infectivity by interacting with the envelope glycoprotein gp120 251
Fusion complexes and CD4-independent Env for the induction of broad spectrum neutralizing antibodies against HIV-1 249
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 246
Expression of HIV-1 NDK m9 env gene in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 246
Development of chimeric humanized monoclonal antibodies against HIV-1 245
Testing the performance of the imputation of MHC region in large datasets when using different reference panels 244
Analisi molecolare delle interazioni fra citomegalovirus umano e leucociti 244
HLA-C is necessary for optimal HIV-1 infection of human peripheral blood CD4 lymphocytes 243
Fusion complexes and CD4-independene Env for the induction of broad spectrum neutralizing antibodies against HIV-1 241
A CRISPR/Cas9 based approach to study the implication of HTLV regulatory proteins in the NF-κB modulation. 239
CRISPR/Cas9 as a tool for the study of the interactions between viruses and host 238
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 237
Analysis of colorectal cancers for human cytomegalovirus presence 237
In silico structural prediction and in vitro functional validation to identify the ACOT8 regions involved in the interaction with HIV-1 Nef 237
Host-virus interactions: HTLV antisense regulatory proteins play a role in the dysregulation of NF-κB pathway 237
5. CRISPR/Cas9 for the Study of the Interactions between Viruses and Host 234
HTLV-1 and HTLV-2 Tax, HBZ and APH-2 interaction with host factors: their involvement in cellular pathways regulation. 232
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 230
2. CRISPR/Cas9 to study virus-host interactions 229
Studiare la regione HLA negli esomi 229
Influenza - Prous Science Integrity 226
P-D9 Human Thioesterase 8 and HIV-1 Nef interaction 226
Molecular characterization of HIV-1 Nef and ACOT8 interaction: insights from in silico structural predictions and in vitro functional assays 224
Presence and role of HLA-C in HIV-1 infection 223
HLA-C increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41. 223
HLA-C associates with Env and Increases HIV-1 infectivity 223
Il ruolo di HLA-C nell'infezione da HIV-1 223
A potential role of RUNX2- RUNT domain in modulating the expression of genes involved in bone metastases: an in vitro study with melanoma cells 223
Runx2 stimulates neoangiogenesis through the Runt domain in melanoma 222
The human T-cell leukemia virus -2 (HTLV-2) antisense protein APH-2 interacts with p65 and inhibits NF-ĸB Tax-2 activation. 221
Expression of a candidate vaccine for AIDS prevention in transgenic tobacco plants 219
HLA-C associates with Env and increases HIV-1 infectivity 218
Expression of HIV-1 NDK m7 and m9 env genes in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 217
Fusion complexes as immunogens for the induction of broad spectrum neutralizing antibodies against HIV-1 215
HLA-C expression levels and binding stability to β2m are involved in HIV-1 infectivity 214
Demonstration of the role of HLA-C in HIV-1 infection by siRNA silencing 212
HIV-1 Env glycoprotein and HLA-C associate and increase HIV-1 infectivity 212
Induction of HIV-1 neutralizing antibodies by fusion complexes 209
Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity 208
HTLV ANTISENSE PROTEINS ROLE IN THE NF-κB MODULATION. 207
Detection and typing of Human Cytomegalovirus DNA in colorectal cancer 206
The Runt domain of RUNX2 induces the migration of melanoma cells to bone 206
Production of a candidate HIV-1 vaccine in transgenic tobacco plants 201
Dissection of HLA-C gene region to investigate its association with complex traits 201
Unsung hero Robert C. Gallo 200
Induction of human immunodeficiency virus (HIV) neutralizing antibodies with fusion complexes 199
Association Analysis Between HIV-1 Env and HLA-C Using Bimolecular Fluorescence Complementation 199
Expression and purification of recombinant HTLV-2 Tax protein in mammalian cells 198
Association analysis between HIV-1 Env and HLAC using bimolecular fluorescence complementation 198
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 196
Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization 195
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 193
Delayed progression to AIDS in HTLV-I/HIV-1 coinfected intravenous drug users 192
Fusion efficiency between the HIV-1 envelope and the target cell membrane is enhanced by the presence of HLA-C molecules 192
New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration 192
NF-κB activation mediated by HTLV-1 transactivator Tax protein is impaired in TRAF3 knock-out cells. 191
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 190
HLA-C and HIV-1: a matter of stability 188
New vaccine strategies for chronic viral infections 186
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 186
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 185
Physical activity prevents cartilage degradation: a metabolomics study pinpoints the involvement of vitamin B6 185
HTLV-1 BASIC LEUCIN ZIPPER FACTOR AND ITS HOMOLOGOUS APH-2 IMPAIR NF-κB ACTIVATION MEDIATED BY THE VIRAL ONCOPROTEIN TAX. 182
Involvement of HLA-C binding stability to β2-microglobulin in HIV-1 infection 181
Benzodiazepine use and HIV-associated neurocognitive impairment: which comes first? 177
HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 176
TRAF3 involvement in the NF-κB pathway deregulation mediated by HTLV-1 Tax protein 176
Cell-based vaccination: rationale for the use of cells co-expressing HIV anv gp120 and HLA class I Cw4 molecules for the induction of neutralizing antibodies 175
Expression and purification of recombinant HTLV-II Tax protein in E.Coli and mammalian cells 174
Vectors derived from antibodies for transfecting substances into cells 173
HLA-C increases HIV-1 infectivity and is associated with gp120 173
HLA-C stability and AIDS progression 173
HTLV deregulation of the NF-κB pathway: an update on tax and antisense proteins role 172
Vectors derived from antibodies for transferring substances into cells 171
Correction for Parolini et al., "Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity" 170
ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19 170
CRISPR/Cas system: an emerging technology in stem cell research 169
Gelsolin activity controls efficient early HIV-1 infection 165
Fusion complexes and CD4-independent gp120s for the induction of broad spectrum anti HIV-1 neutralizing antibodies 164
TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins 164
Monitoraggio virologico delle infezioni da citomegalovirus umano (HCMV) nel paziente con AIDS 163
Induction of human immunodeficiency virus (HIV) broad spectrum neutralizing antibodies with fusion complexes. 163
Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma 163
A new approach to the development of a broadly neutralizing anti-HIV vaccine 162
A simple method for human cytomegalovirus (HCMV) DNA quantitation in clinical samples 161
Single-chain antibody fragments for transferring substance 159
Quantificazione del DNA di citomegalovirus umano (HCMV) nei leucociti di pazienti immunocompromessi mediante polymerase chain reaction 159
A fast and reliable method for detecting SNP rs67384697 (Hsa-miR-148a binding site) by a single run of allele-specific real-time PCR 159
Exploring the Interplay of RUNX2 and CXCR4 in Melanoma Progression 158
Totale 23.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.128
article - articoli 47.526
book - libri 5.018
conference - conferenze 55.560
curatela - curatele 0
other - altro 0
patent - brevetti 1.331
selected - selezionate 0
volume - volumi 1.693
Totale 222.256
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022989 0 0 0 77 47 48 48 99 54 67 146 403
2022/20233.232 253 312 304 571 288 755 27 196 363 40 75 48
2023/20243.664 66 145 153 180 189 2.278 114 96 19 73 201 150
2024/20254.121 268 264 140 623 174 87 297 210 659 283 272 844
2025/202612.381 811 617 971 1.922 2.918 897 1.248 681 1.021 854 176 265
2026/20273.158 208 354 764 1.832 0 0 0 0 0 0 0 0
Totale 35.561